Biological Seed Treatment Market Size, Trends, Latest Insights, Analysis and Forecast

The biological seed treatment market size is projected to reach USD 1.7 billion by 2025, and it was valued at USD 0.9 billion in 2020. It is expected to grow at a CAGR of 11.9%. The market is influenced by the adoption of sustainable agricultural practices, along with strong investments being made by major market players in the research and development of these products. The agricultural and environmental benefits associated with these biological seed treatment solutions are the major factors contributing to the growth of this market globally. Beneficial microorganisms and plant extracts are projected to act as important tools that could help reduce the usage of synthetic fertilizers and chemical pesticides, thereby reducing investments by farmers and environmental risks.

Biological Seed Treatment Market Growth Drivers:

• Increasing Demand for Sustainable Agriculture: Consumers and farmers alike are increasingly prioritizing sustainable agricultural practices. Biological seed treatment methods, which utilize natural resources and reduce the need for chemical inputs, align with the growing demand for environmentally friendly farming.
• Rising Awareness about Crop Protection: With a heightened awareness of the importance of crop protection, farmers are seeking effective and safe solutions to safeguard their crops against diseases and pests. Biological seed treatments, often derived from beneficial microorganisms, provide a natural and eco-friendly alternative to traditional chemical treatments.
• Government Initiatives and Regulations: Governments worldwide are implementing regulations and initiatives to promote sustainable agriculture and reduce the environmental impact of farming practices. Incentives and support for the adoption of biological seed treatments play a pivotal role in driving market growth.
• Advancements in Biotechnology: Ongoing advancements in biotechnology have led to the development of innovative biological seed treatment products. These technologies enhance the efficacy of seed treatments, making them more appealing to farmers seeking improved yield and crop quality.
• Improved Crop Performance and Yield: Biological seed treatments not only protect crops from diseases and pests but also contribute to improved plant growth, root development, and overall crop yield. As farmers witness tangible benefits in terms of productivity, the adoption of biological seed treatments is expected to rise.
• Growing Organic Farming Practices: The global trend towards organic farming has fueled the demand for biological seed treatments. Organic farmers, in particular, prefer natural and non-synthetic solutions to maintain the integrity of their organic produce.
• Collaborations and Partnerships: Increased collaboration between seed treatment companies, agricultural research institutions, and biotechnology firms has accelerated research and development efforts. Partnerships enable the sharing of expertise and resources, leading to the creation of more effective biological seed treatment solutions.

Biological Seed Treatment Market Driver: Environmental concerns associated with chemical seed treatment

The demand for biological seed treatment has significantly increased as a result of high awareness of their potential and growing attention to the environmental and health risks associated with conventional chemicals. Chemical seed treatments are detrimental to the environment and pose a serious risk to pollinators. The neonicotinoid class of insecticides is considered highly toxic to honeybees. Microorganisms employed as active substances in pest management are recognized as generally safe for the environment and non-target species, in comparison with synthetic chemicals.

North America region’s increasing preference for high quality produce

The increasing agricultural practices and requirement for high-quality agricultural produce are factors that are projected to drive the biological seed treatment market in this region. The government policies adopted by developed countries for the ban on key active ingredients are the major factors encouraging the growth of this market in North America region. Hence, North America is projected to be the fastest-growing region in the global market. R&D investments for the development of biological seed treatment and the installation of new production capacities by key players are projected to drive market growth in the next five years.

Biological Seed Treatment Market Share:

Key players in this market include BASF SE (Germany), Bayer AG (Germany), Novozymes A/S (Denmark), Syngenta Group (Switzerland), Corteva Agriscience (US), Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), and Italpollina (Italy), These major players in this market are focusing on increasing their presence through expansions & investments, mergers & acquisitions, partnerships, joint ventures, and agreements. These companies have a strong presence in North America, Asia Pacific, and Europe. They also have manufacturing facilities, along with strong distribution networks across these regions.

Biological Seed Treatment Market to See Major Growth by 2025

The biological seed treatment market is projected to reach USD 1.7 billion by 2025, from USD 0.9 billion in 2020, at a CAGR of 11.9% during the forecast period. The market has been growing at a significant rate due to the increasing need for a sustainable approach in agricultural operations in developed countries. Strong research funding by key manufacturers on product development, such as compatible combinations of biological and chemical components, is expected to drive the growth of the market over the next five years.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

Companies such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group (Switzerland), Corteva Agriscience (US) have been focusing on technological innovations in seed inoculation and patent registrations for new product launches to strengthen their market base in the concerned market. Apart from these companies, other biological seed treatment companies include Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), Italpollina (Italy), and Incotec (Netherlands), which have been strengthening their market position through product launches and distribution & technology agreements.

Bayer AG (Germany) is one of the active players in the biological seed treatment market. A considerable amount of Bayer revenue goes into research & development activities to offer innovative products and practices to the farming community across the world. Bayer has successfully pushed products into the market through its farmer engagement programs. Bayer has made significant investments in the acquisition of seed treatment technology providers and established research collaborations for the development of microbial seed treatment products through its SeedGrowth business unit. The acquisition of Monsanto (US) in 2018 has been a big milestone in Bayer’s history of developments, which has allowed the company to enhance its research on new technologies for improving the available solutions for crop protection. In 2018, the company received marketing authorization in many countries for new mixtures and formulations, which will further strengthen its global presence. It has also expanded its global presence with high levels of investments in R&D activities to serve its customers with innovative products in the biological seed treatment market.

Syngenta Group (Switzerland) has been a leading player in the agricultural industry by offering diverse innovative solutions to the market. Through its product investment and partnership approach, the company focuses on delivering sustainable solutions through its seed treatment technology in order to capitalize on a growing market demand for biological solutions and progress to a formidable position at the preliminary stage of the market. It has a strong brand image and early mover advantage due to the introduction of Clariva, the first biological nematicide for seed treatment. In October 2020, Syngenta Group announced the acquisition of Valagro (Italy), a leading biologicals company, through its business unit, Syngenta Crop Protection. Through this strategy, Syngenta Crop Protection positions itself as one of the key global companies to shape the rapidly growing biologicals market, which is set to nearly double in size over the next five years.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=162422288

The increasing agricultural practices and requirement of high-quality agricultural produce are factors that are projected to drive the growth of the biological seed treatment market in this region. The government policies adopted by developed countries for the ban on key active ingredients are the major factors encouraging the growth of this market in the North America region. Hence, North America is projected to be the fastest-growing region in the global market. R&D investments for the development of biological seed treatment and the installation of new production capacities by key players are projected to drive the market growth in the next five years.

Biological Seed Treatment Market: Growth Opportunities and Recent Developments

The biological seed treatment market is projected to reach USD 1.7 billion by 2025, and it was valued at USD 0.9 billion in 2020. It is expected to grow with CAGR of 11.9%. The global demand for biological seed treatment solutions is increasing as they ensure the farmers in protecting their potential yield, quality by minimizing the crop losses. Although, the biological seed treatment market is a small sector in the global agrochemical industry, the market has been growing at a significant rate due to agricultural and environmental benefits globally and increasing need for a sustainable approach in agricultural operations in developed countries. Strong research funding by key manufacturers for product development is projected to drive the growth of the market over the next five years.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

Driver: Environmental concerns associated with chemical seed treatment

The demand for biological seed treatment has significantly increased as a result of high awareness of their potential and the growing attention to the environmental and health risks associated with conventional chemicals. Chemical seed treatments are detrimental to the environment and pose a serious risk to pollinators. The neonicotinoid class of insecticides is considered highly toxic to honeybees. Microorganisms employed as active substances in pest management are recognized as generally safe for the environment and non-target species, in comparison with synthetic chemicals.

Challenges: Inconsistent performance and incompatibility with certain pesticides

The features of biological seed treatments that have discouraged investment are their inconsistent results. The most common problems encountered during the usage of such products include desiccation and environmental conditions that discourage their growth. Successful inoculants with one crop may not work as effectively with another crop. For instance, Trichoderma is more effective for the increase in yield in tomatoes than cucumbers. Choosing just one or two microbes is not as effective as loading with an entire community. However, effectiveness can sometimes be increased by a combination of microbes, with various growth requirements. For instance, fungi can be combined with PGPR.

Fastest-growing segment by function: Seed protection segment

On the basis of function, the global market has broadly been segmented into seed enhancement and seed protection. Biological seed treatments aimed at seed protection provide targeted control of certain pests and fungal diseases during the early seedling stage. Biological seed treatments are used on multiple crops to control a variety of pests. It ensures uniform stand establishment through defense against numerous soil-borne pathogens and insects.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=162422288

North America region’s increasing preference for high quality produce

The increasing agricultural practices and requirement of high-quality agricultural produce are factors that are projected to drive the biological seed treatment market growth in this region. The government policies adopted by developed countries for the ban on key active ingredients are the major factors encouraging the growth of this market in North America region. Hence, North America is projected to be the fastest-growing region in the global market. R&D investments for the development of biological seed treatment and installation of new production capacities by key players are projected to drive the market growth in the next five years.

Key players in this market include BASF SE (Germany), Bayer AG (Germany), Novozymes A/S (Denmark), Syngenta Group (Switzerland), Corteva Agriscience (US), Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), and Italpollina (Italy)

Biological Seed Treatment Market to Witness Unprecedented Growth in Coming Years

The biological seed treatment market is projected to reach USD 1.7 billion by 2025, and it was valued at USD 0.9 billion in 2020. It is expected to grow with CAGR of 11.9%. The market is influenced by the adoption of sustainable agricultural practices, along with strong investments being made by major market players in the research and development of these products. The agricultural and environmental benefits associated with these biological seed treatment solutions are the major factors contributing to the growth of this market globally. Beneficial microorganisms and plant extracts are projected to act as important tools that could help reduce the usage of synthetic fertilizers and chemical pesticides, thereby reducing the investments by farmers and environmental risks.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

The demand for biological seed treatment has significantly increased as a result of high awareness of their potential and the growing attention to the environmental and health risks associated with conventional chemicals. Chemical seed treatments are detrimental to the environment and pose a serious risk to pollinators. The neonicotinoid class of insecticides is considered highly toxic to honeybees. Microorganisms employed as active substances in pest management are recognized as generally safe for the environment and non-target species, in comparison with synthetic chemicals.

The Microbial segment is projected to be the largest and fastest growing type of biological seed treatment market during the review period, in terms of value.

The biological seed treatment is categorized into two types namely microbial and botanicals. The microbial segment accounted for the largest share in the global biological seed treatment market due to the higher demand for biofungicides and bioinsecticides. These microbial seed treatments is carried out by beneficial microorganisms which can reduce the fertilizer and pesticide applications and increases the yields, with economical price.

Fastest-growing segment by function: Seed protection segment

On the basis of function, the global market has broadly been segmented into seed enhancement and seed protection. Biological seed treatments aimed at seed protection provide targeted control of certain pests and fungal diseases during the early seedling stage. Biological seed treatments are used on multiple crops to control a variety of pests. It ensures uniform stand establishment through defense against numerous soil-borne pathogens and insects.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=162422288

North America region’s increasing preference for high quality produce

The increasing agricultural practices and requirement of high-quality agricultural produce are factors that are projected to drive the biological seed treatment market growth in this region. The government policies adopted by developed countries for the ban on key active ingredients are the major factors encouraging the growth of this market in North America region. Hence, North America is projected to be the fastest-growing region in the global market. RD investments for the development of biological seed treatment and installation of new production capacities by key players are projected to drive the market growth in the next five years.

Key players in this market include BASF SE (Germany), Bayer AG (Germany), Novozymes A/S (Denmark), Syngenta Group (Switzerland), Corteva Agriscience (US),  Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), and Italpollina (Italy).

Biological Seed Treatment Market: Growth Opportunities and Recent Developments

The Biological Seed Treatment Market has witnessed a surge in demand in recent years, owing to the rising awareness about sustainable agriculture practices and the adverse effects of chemical seed treatment on soil and the environment. The biological seed treatment market is projected to reach USD 1.7 billion by 2025, and it was valued at USD 0.9 billion in 2020. It is expected to grow with CAGR of 11.9%.

Growth Drivers for Biological Seed Treatment Market:

• Rising demand for organic food products
• Increasing awareness about sustainable agriculture practices
• Favorable government initiatives promoting eco-friendly farming practices
• Growing need for crop protection against diseases and pests
• Cost-effectiveness of biological seed treatment

Key Players in the Biological Seed Treatment Market:

1. BASF SE
2. Syngenta AG
3. Bayer AG
4. DuPont de Nemours, Inc.
5. Koppert Biological Systems

Challenges and Opportunities in Biological Seed Treatment Market:

• Lack of awareness about the benefits of biological seed treatment
• Limited availability of commercial products
• High cost of research and development
• Challenges in scaling up the production of beneficial microorganisms
• Growing demand for organic products creates opportunities for biological seed treatment.

Regional Analysis of Biological Seed Treatment Market:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East Africa

Future Prospects of Biological Seed Treatment Market:

• Increasing demand for sustainable agriculture practices to drive the market growth
• Growing investments in research and development activities to develop new products
• Adoption of precision farming techniques to boost the efficacy of biological seed treatment
• Strategic partnerships and collaborations between key players to expand market reach
• Technological advancements in the production of beneficial microorganisms to drive innovation in the market.

Bullet Points:

Biological seed treatment is gaining popularity among farmers for its eco-friendly nature and effectiveness in enhancing crop yield and disease resistance.

The market is driven by factors such as rising demand for organic food products, increasing awareness about sustainable agriculture practices, and favorable government initiatives promoting eco-friendly farming practices.

Key players in the market include BASF SE, Syngenta AG, Bayer AG, DuPont de Nemours, Inc., and Koppert Biological Systems.

The market faces challenges such as lack of awareness about the benefits of biological seed treatment, limited availability of commercial products, and high cost of research and development.

However, growing demand for organic products and increasing investments in research and development activities create opportunities for market growth.

The market is expected to witness significant growth in North America, Europe, Asia Pacific, Latin America, and the Middle East Africa regions.

Future prospects of the market include increasing demand for sustainable agriculture practices, adoption of precision farming techniques, and technological advancements in the production of beneficial microorganisms.

Biological Seed Treatment Market Growth Opportunities by 2025

The global biological seed treatment market is projected to reach USD 1.7 billion by 2025, from USD 0.9 billion in 2020, at a CAGR of 11.9% during the forecast period. The market has been growing at a significant rate due to the increasing need for a sustainable approach in agricultural operations in developed countries. Strong research funding by key manufacturers on product development such as compatible combinations of biological and chemical components is expected to drive the growth of the market over the next five years.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

Companies such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group (Switzerland), Corteva Agriscience (US) have been focusing on technological innovations in seed inoculation and patent registrations for new product launches to strengthen their market base in the concerned market. Apart from these companies, other biological seed treatment companies include Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), Italpollina (Italy), and Incotec (Netherlands), which have been strengthening their market position through product launches and distribution technology agreements.

Expansions were the most used strategy by the key players in the seed treatment market. RD centers/innovation labs were inaugurated by companies such as BASF SE (Germany), Syngenta Group (Switzerland), Koppert Biological Systems (Netherlands), and Incotec (Netherlands). Due to the overall growing demand for biostimulants and microbial-based technologies, companies such as BASF SE (Germany), Incotec (Netherlands), Valent BioSciences (US), and Italpollina (Italy) have invested in the upgradation expansion of their existing facilities or establishment of new manufacturing facilities.

Bayer AG (Germany) is one of the active players in the biological seed treatment market. A considerable amount of Bayer revenue goes into research development activities to offer innovative products and practices to the farming community across the world. Bayer has successfully pushed products into the market through its farmer engagement programs. Bayer has made significant investments in the acquisition of seed treatment technology providers and established research collaborations for the development of microbial seed treatment products through its SeedGrowth business unit. The acquisition of Monsanto (US) in 2018, has been a big milestone in Bayer’s history of developments, which has allowed the company to enhance its research on new technologies for improving the available solutions for crop protection. In 2018, the company received marketing authorization in many countries for new mixtures and formulations, which will further strengthen its global presence. It has also expanded its global presence, clubbed with high levels of investments in RD activities to serve its customers with innovative products in biological seed treatment market.

Syngenta Group (Switzerland) has been a leading player in the agricultural industry by offering diverse innovative solutions to the market place. Through its product investment partnership approach, the company focuses on delivering sustainable solutions through its seed treatment technology in order to capitalize on a growing market demand for biological solutions, and progress to a formidable position at the preliminary stage of the market. It has a strong brand image and early mover advantage due to the introduction of Clariva, the first biological nematicide for seed treatment. In October 2020, Syngenta Group announced the acquisition of Valagro (Italy), a leading Biologicals company, through its business unit Syngenta Crop Protection. Through this strategy, Syngenta Crop Protection positions itself as one of the key global companies to shape the rapidly growing biologicals market, which is set to nearly double in size over the next five years.

Speak to Analyst @ 
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162422288

The global biological seed treatment market was dominated by North America, followed by Europe, APAC and South American regions. This is due to the countries in North America are set to rapid adoption of modern agricultural technologies and increase in the ban of certain chemical formulations inorder to develop a sustainable approach to diminish the environmental risks caused by pesticides usage.

Biological Seed Treatment Market Will Hit Big Revenues In Future

The global biological seed treatment market is projected to reach USD 1.7 billion by 2025, from USD 0.9 billion in 2020, at a CAGR of 11.9% during the forecast period. The market has been growing at a significant rate due to the increasing need for a sustainable approach in agricultural operations in developed countries. Strong research funding by key manufacturers on product development such as compatible combinations of biological and chemical components is expected to drive the growth of the market over the next five years.

 

 

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

 

Companies such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group (Switzerland), Corteva Agriscience (US) have been focusing on technological innovations in seed inoculation and patent registrations for new product launches to strengthen their market base in the concerned market. Apart from these companies, other biological seed treatment companies include Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), Italpollina (Italy), and Incotec (Netherlands), which have been strengthening their market position through product launches and distribution & technology agreements.

 

Expansions were the most used strategy by the key players in the seed treatment market. R&D centers/innovation labs were inaugurated by companies such as BASF SE (Germany), Syngenta Group (Switzerland), Koppert Biological Systems (Netherlands), and Incotec (Netherlands). Due to the overall growing demand for biostimulants and microbial-based technologies, companies such as BASF SE (Germany), Incotec (Netherlands), Valent BioSciences (US), and Italpollina (Italy) have invested in the upgradation & expansion of their existing facilities or establishment of new manufacturing facilities.

 

Bayer AG (Germany) is one of the active players in the biological seed treatment market. A considerable amount of Bayer revenue goes into research & development activities to offer innovative products and practices to the farming community across the world. Bayer has successfully pushed products into the market through its farmer engagement programs. Bayer has made significant investments in the acquisition of seed treatment technology providers and established research collaborations for the development of microbial seed treatment products through its SeedGrowth business unit. The acquisition of Monsanto (US) in 2018, has been a big milestone in Bayer’s history of developments, which has allowed the company to enhance its research on new technologies for improving the available solutions for crop protection. In 2018, the company received marketing authorization in many countries for new mixtures and formulations, which will further strengthen its global presence. It has also expanded its global presence, clubbed with high levels of investments in R&D activities to serve its customers with innovative products in biological seed treatment market.

 

Syngenta Group (Switzerland) has been a leading player in the agricultural industry by offering diverse innovative solutions to the market place. Through its product investment & partnership approach, the company focuses on delivering sustainable solutions through its seed treatment technology in order to capitalize on a growing market demand for biological solutions, and progress to a formidable position at the preliminary stage of the market. It has a strong brand image and early mover advantage due to the introduction of Clariva, the first biological nematicide for seed treatment. In October 2020, Syngenta Group announced the acquisition of Valagro (Italy), a leading Biologicals company, through its business unit Syngenta Crop Protection. Through this strategy, Syngenta Crop Protection positions itself as one of the key global companies to shape the rapidly growing biologicals market, which is set to nearly double in size over the next five years.

 

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162422288

 

The increasing agricultural practices and requirement for high-quality agricultural produce are factors that are projected to drive the biological seed treatment market growth in this region. The government policies adopted by developed countries for the ban on key active ingredients are the major factors encouraging the growth of this market in the North America region. Hence, North America is projected to be the fastest-growing region in the global market. R&D investments for the development of biological seed treatment and installation of new production capacities by key players are projected to drive market growth in the next five years.

Biological Seed Treatment Market to Record Steady Growth by 2025

The report "Biological Seed Treatment Market by Type (Microbials and Botanicals), Crop (Corn, Wheat, Soybean, Cotton, Sunflower, and Vegetable Crops), Function (Seed Protection and Seed Enhancement), and Region - Global Forecast to 2025". The global market is projected to reach USD 1.7 billion by 2025, from USD 0.9 billion in 2020, at a CAGR of 11.9% during the forecast period. The market is driven by factors such as high demand for sustainable agriculture in the global market, lesser risks of exceeding pesticide MRLs, and insurance to seed investments.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

Seed enhancement segment is estimated to be the largest market for biological seed treatment during the forecast period

The seed enhancement segment comprises biofertilizers and biostimulants. Cumulatively, they were estimated to account for a major share of the total market in 2020. The product portfolio of major companies involved in the biological seed treatment market is more focused toward biofertilizers and biostimulants. Thus, the market for biofertilizers is the largest and is expected to maintain its growth momentum in the future.

Soybean segment is projected to be the fastest-growing during the forecast period

Soybean is an important source of protein and oil for the feed and chemical industries. Despite being a legume crop with natural nodule formations, seed inoculants are used to further improve root length, effective water absorption, and nutrient uptake, thereby reducing early senescence, and improving grain quality. Thus, the use of biological seed treatments in soybean crops is expected to grow at the highest rate during the forecast period.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162422288

North America is projected to be the fastest-growing market

The major reason for the biological seed treatment market experiencing such a high growth rate is the highly streamlined product registration process, which makes it easier for most private companies to launch their products easily. Lower investment requirement and limited gestation period involved in the development and commercialization of biological products are key factors attracting a large number of startup companies in the industry. Additionally, growing awareness among consumers against synthetic chemicals has also led to a higher adoption of these products.

This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It also includes the profiles of leading companies such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group(Switzerland), Corteva Agriscience (US), Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), Italpollina (Italy), Marrone Bio Innovation (US), Certis Europe (Netherlands), UPL Limited (India), Novozymes A/S (Denmark), IPL Biologicals (India), Rizobacter (Argentina), Bioworks, Inc (US), Advanced Biological Marketing (US), Kan Biosys (India), and Incotec (Netherlands).

Latest Regulatory Trends Impacting the Biological Seed Treatment Market

The global biological seed treatment market is estimated to be valued at USD 0.9 billion in 2020 and is projected to reach USD 1.7 billion by 2025, recording a CAGR of 11.9%.The market is influenced by the adoption of sustainable agricultural practices, along with strong investments being made by major market players in the research and development of these products. The agricultural and environmental benefits associated with these biological seed treatment solutions are the major factors contributing to the growth of this market globally. Beneficial microorganisms and plant extracts are projected to act as important tools that could help reduce the usage of synthetic fertilizers and chemical pesticides, thereby reducing the investments by farmers and environmental risks.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

Driver: Environmental concerns associated with chemical seed treatment

The demand for biological seed treatment has significantly increased as a result of high awareness of their potential and the growing attention to the environmental and health risks associated with conventional chemicals. Chemical seed treatments are detrimental to the environment and pose a serious risk to pollinators. The neonicotinoid class of insecticides is considered highly toxic to honeybees. Microorganisms employed as active substances in pest management are recognized as generally safe for the environment and non-target species, in comparison with synthetic chemicals.

By crop type, the soybean segment is projected to be the fastest-growing segment in the seed treatment market during the forecast period.

The soybean crop requires significant exposure to nitrogen for growth and development, which can be supplied through biological fixation by seed inoculants. Hence, the market for biological seed treatment in soybean is projected to grow at the fastest rate during the forecast period. Bio-nematicide seed treatments help protect the roots from soybean cyst nematode (SCN) feeding by parasitizing the nematode, inhibiting nerve transmission, or creating a protective barrier around the roots to repel nematodes.

By type, the microbials segment is projected to dominate the seed treatment market during the forecast period.

The biological seed treatment market, by type, has been segmented into microbials, botanicals, and others (biofermentation products and natural polymers & derivatives). The microbials industry dominated the market in 2020, due to the increasing demand for microbial seed treatments, in field crops such as soybean and corn.

Many key companies, such as Bayer AG (Germany), Syngenta Group (Switzerland), and Corteva Agriscience (US), offer innovative biological seed treatment solutions for controlling seed and soil-borne diseases in a broad range of crops. This exponential growth in this North America region is attributed to government subsidies, increasing need to improve and protect food production, and rising awareness of biological seed treatment.

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162422288

North America is projected to be the fastest-growing market

The major reason for the biological seed treatment market experiencing such a high growth rate is the highly streamlined product registration process, which makes it easier for most private companies to launch their products easily. Lower investment requirements and limited gestation period involved in the development and commercialization of biological products are key factors attracting a large number of startup companies in the industry. Additionally, growing awareness among consumers against synthetic chemicals has also led to higher adoption of these products.

This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It also includes the profiles of leading companies such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group(Switzerland), Corteva Agriscience (US), Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), Italpollina (Italy), Marrone Bio Innovation (US), Certis Europe (Netherlands), UPL Limited (India), Novozymes A/S (Denmark), IPL Biologicals (India), Rizobacter (Argentina), Bioworks, Inc (US), Advanced Biological Marketing (US), Kan Biosys (India), and Incotec (Netherlands).

Biological Seed Treatment Market to See Major Growth by 2025

The biological seed treatment market is projected to reach USD 1.7 billion by 2025, from USD 0.9 billion in 2020, at a CAGR of 11.9% during the forecast period. The market has been growing at a significant rate due to the increasing need for a sustainable approach in agricultural operations in developed countries. Strong research funding by key manufacturers on product development such as compatible combinations of biological and chemical components is expected to drive the growth of the market over the next five years.

Companies such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group (Switzerland), Corteva Agriscience (US) have been focusing on technological innovations in seed inoculation and patent registrations for new product launches to strengthen their market base in the concerned market. Apart from these companies, other biological seed treatment companies include Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), Italpollina (Italy), and Incotec (Netherlands), which have been strengthening their market position through product launches and distribution & technology agreements.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

Expansions were the most used strategy by the key players in the seed treatment market. R&D centers/innovation labs were inaugurated by companies such as BASF SE (Germany), Syngenta Group (Switzerland), Koppert Biological Systems (Netherlands), and Incotec (Netherlands). Due to the overall growing demand for biostimulants and microbial-based technologies, companies such as BASF SE (Germany), Incotec (Netherlands), Valent BioSciences (US), and Italpollina (Italy) have invested in the upgradation & expansion of their existing facilities or establishment of new manufacturing facilities.

Bayer AG (Germany) is one of the active players in the biological seed treatment market. A considerable amount of Bayer revenue goes into research & development activities to offer innovative products and practices to the farming community across the world. Bayer has successfully pushed products into the market through its farmer engagement programs. Bayer has made significant investments in the acquisition of seed treatment technology providers and established research collaborations for the development of microbial seed treatment products through its SeedGrowth business unit. The acquisition of Monsanto (US) in 2018, has been a big milestone in Bayer’s history of developments, which has allowed the company to enhance its research on new technologies for improving the available solutions for crop protection. In 2018, the company received marketing authorization in many countries for new mixtures and formulations, which will further strengthen its global presence. It has also expanded its global presence, clubbed with high levels of investments in R&D activities to serve its customers with innovative products in biological seed treatment market.

Syngenta Group (Switzerland) has been a leading player in the agricultural industry by offering diverse innovative solutions to the market place. Through its product investment & partnership approach, the company focuses on delivering sustainable solutions through its seed treatment technology in order to capitalize on a growing market demand for biological solutions, and progress to a formidable position at the preliminary stage of the market. It has a strong brand image and early mover advantage due to the introduction of Clariva, the first biological nematicide for seed treatment. In October 2020, Syngenta Group announced the acquisition of Valagro (Italy), a leading Biologicals company, through its business unit Syngenta Crop Protection. Through this strategy, Syngenta Crop Protection positions itself as one of the key global companies to shape the rapidly growing biologicals market, which is set to nearly double in size over the next five years.

North America is projected to be the fastest-growing market

The major reason for the biological seed treatment market experiencing such a high growth rate is the highly streamlined product registration process, which makes it easier for most private companies to launch their products easily. Lower investment requirements and limited gestation period involved in the development and commercialization of biological products are key factors attracting a large number of startup companies in the industry. Additionally, growing awareness among consumers against synthetic chemicals has also led to higher adoption of these products.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162422288

Recent Developments:

• In December 2020, Kopper Biological Systems (Netharlands) acquired Geocom, which is headquartered in Lençóis Paulista, São Paulo, Brazil. Geocom operates in the field of agricultural technology and is a pioneer in image geoprocessing and the first to develop an exclusive technology for the application of biological agents via drones in Brazil. The goal of the company is to increase the precision of agri-farming, which is crucial for offering biologicals to the fields.
• In August 2020, Valent BioSciences (US), opened a new facility in San Ramon, the North American Innovation Center (NAIC), that physically unites employees from its California technical center in Dublin and headquarters in Walnut Creek. It is now easier for the newly centralized team to share information in real-time face-to-face, which would increase its efficiency, agility, and creativity, and ultimately, benefit the farmers in the field.
• In October 2020, Syngenta Group announced the acquisition of Valagro, a leading Biologicals company, through its business unit Syngenta Crop Protection. Through this strategy, Syngenta Crop Protection positions itself as one of the key global companies to shape the rapidly growing biologicals market, which is set to nearly double in size over the next five years.

Biological Seed Treatment Market to Witness Unprecedented Growth in Coming Years

The report "Biological Seed Treatment Market by Type (Microbials and Botanicals), Crop (Corn, Wheat, Soybean, Cotton, Sunflower, and Vegetable Crops), Function (Seed Protection and Seed Enhancement), and Region - Global Forecast to 2025", is projected to reach USD 1.7 billion by 2025, from USD 0.9 billion in 2020, at a CAGR of 11.9% during the forecast period. The market is driven by factors such as high demand for sustainable agriculture in the global market, lesser risks of exceeding pesticide MRLs, and insurance to seed investments.

Opportunities: Use of bio-priming techniques for improved efficacy

Bio-priming is a process of a biological seed treatment that refers to a combination of seed hydration and inoculation of the seed with microbes. In most cases, microbial inoculants, such as plant growth-promoting rhizo-microorganisms (bacteria or fungi), are used for the purpose of bio-priming of seeds. It is an environment-friendly ecological approach using selected microorganisms that enhance plant growth by producing plant growth-promoting substances, enhancing nutrient uptake, or protecting seedlings/plants against soil-/seed-borne plant pathogenic organisms. The use of such techniques is on the rise as chemicals used for seed treatment mostly act as contact fungicides that are unable to protect the plants from foliar pathogens during the later stages of crop growth.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

Challenges: Inconsistent performance and incompatibility with certain pesticides

The features of biological seed treatments that have discouraged investment are their inconsistent results. The most common problems encountered during the usage of such products include desiccation and environmental conditions that discourage their growth. Successful inoculants with one crop may not work as effectively with another crop. For instance, Trichoderma is more effective for the increase in yield in tomatoes than cucumbers. Choosing just one or two microbes is not as effective as loading with an entire community. However, effectiveness can sometimes be increased by a combination of microbes, with various growth requirements. For instance, fungi can be combined with PGPR.

By type, microbials segment is projected to dominate the seed treatment market during the forecast period.

The biological seed treatment market, by type, has been segmented into microbials, botanicals, and others (biofermentation products and natural polymers & derivatives). The microbials industry dominated the market in 2020, due to the increasing demand for microbial seed treatments, in field crops such as soybean and corn.

Many key companies, such as Bayer AG (Germany), Syngenta Group (Switzerland), and Corteva Agriscience (US), offer iinovative biological seed treatment solutions for controlling seed and soil-borne diseases in a broad range of crops. This exponential growth in this North America region is attributed to government subsidies, increasing need to improve and protect food production, and rising awareness of biological seed treatment.

Make an Inquiry:

https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=162422288

North America is projected to be the fastest-growing market

The major reason for the biological seed treatment market experiencing such a high growth rate is the highly streamlined product registration process, which makes it easier for most private companies to launch their products easily. Lower investment requirements and limited gestation period involved in the development and commercialization of biological products are key factors attracting a large number of startup companies in the industry. Additionally, growing awareness among consumers against synthetic chemicals has also led to higher adoption of these products.

This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It also includes the profiles of leading companies such as BASF SE (Germany), Bayer AG (Germany), Syngenta Group(Switzerland), Corteva Agriscience (US), Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert Biological Systems (Netherlands), Italpollina (Italy), Marrone Bio Innovation (US), Certis Europe (Netherlands), UPL Limited (India), Novozymes A/S (Denmark), IPL Biologicals (India), Rizobacter (Argentina), Bioworks, Inc (US), Advanced Biological Marketing (US), Kan Biosys (India), and Incotec (Netherlands).

Biological Seed Treatment Market to Witness Unprecedented Growth in Coming Years

The report "Biological Seed Treatment Market by Type (Microbials and Botanicals), Crop (Corn, Wheat, Soybean, Cotton, Sunflower, and Vegetable Crops), Function (Seed Protection and Seed Enhancement), and Region - Global Forecast to 2022", The biological seed treatment market is projected to reach USD 1,251.4 Million by 2022, from USD 739.3 Million in 2017, at a CAGR of 11.10% from 2017. The market is driven by factors such as high demand for sustainable agriculture in the global market, lesser risks of exceeding pesticide MRLs, and insurance to seed investments.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162422288

Microbials segment is projected to be the fastest-growing from 2017 to 2022

Microbial seed treatment includes bacterial and fungal seed treatment. Seeds treatment provides an efficient mechanism for the placement of microbial inoculum in the soil environment, where they are appropriately positioned to colonize the seedling & roots and protect them against soil-borne diseases and pests. Thus, the microbials segment is projected to grow at the highest rate during the forecast period.

Corn segment led the market with the largest share in 2016

The demand for biological seed treatment in corn has been witnessing substantial growth in the European and American regions, due to the significant requirement of corn as animal protein and ethanol in the feed and automobile industries, respectively. Thus, the corn segment accounted for the major share in the biological seed treatment market.

Opportunity: Bio encapsulation technologies for improved environmental persistence

Research and developments in the field of agricultural practices have been moving toward the production of inoculants, which could eventually lead to the advent of improved and advanced formulations to ease application processes and improve the viability of products. Conventional forms of formulations, solid or liquid, lead to several problems related to the low viability of microorganisms during the storage and application process. However, this problem can be addressed by the immobilization of microorganisms. This immobilization highly improves the shelf-life and efficacy of the formulation, keeping it viable for a longer duration. Bioencapsulation technologies could also result in a controlled microbial release, thereby improving application efficacy. Such technologies have the ability of greatly improving the persistence of biological seed treatments in the soil environment and thereby, leading to a thriving market for the product.

Speak to Analyst: 

https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=162422288

North America is projected to be the fastest-growing market

The major reason for the biological seed treatment market experiencing such a high growth rate is the highly streamlined product registration process, which makes it easier for most private companies to launch their products easily. Lower investment requirement and limited gestation period involved in the development and commercialization of biological products are key factors attracting a large number of startup companies in the industry. Additionally, growing awareness among consumers against synthetic chemicals has also led to a higher adoption of these products.

This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It also includes the profiles of leading companies such as BASF (Germany), Bayer (Germany), Syngenta (Switzerland), Monsanto (US), DuPont (US), Valent BioSciences (US), Verdesian Life Sciences (US), Plant Health Care (US), Precision Laboratories (US), Koppert (Netherlands), Italpollina (Italy), and Incotec (Netherlands).

Recent Developments:

• In March 2019, Corteva Agriscience (formerly known as DowDuPont) inaugurated new center of technologies applied to seed in Aussonne (France), this would help company to enhance yield of farmers in this region. 
• In September 2018, Plant Health Care launched Harpin αβ product for seed treatment applications to corn, this would help the company to tap huge market for corn spread over more than 90 million acres.
• In July 2017, Syngenta and Valagro (Italy) signed an agreement under the terms of which Valagro would supply biostimulants to Syngenta for seed treatments. With the combined expertise of the two companies, Syngenta was expected to launch EPIVIO Energy by 2018.
• In July 2017, Bayer launched two inoculant technologies for seed treatment in Brazil. Bayer in partnership with Novozymes, developed the inoculant TSI, for industrial seed treatment. For the on-farm seed treatment, inoculant Biagro 10 and Biagro Líquido NG were launched by the company.